References
- SternMEBeuermanRWFoxRIGaoJMircheffAKPflugfelderSCThe pathology of dry eye: the interaction between the ocular surface and lacrimal glandsCornea19981765845899820935
- PerryHDDry eye disease: pathophysiology, classification, and diagnosisAm J Manag Care2008143 SupplS79S8718452371
- PflugfelderSCSolomonASternMEThe diagnosis and management of dry eye: a twenty-five-year reviewCornea200019564464911009316
- The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop2007Ocul Surf200752759217508116
- BehrensADoyleJJSternLDysfunctional tear syndrome: a Delphi approach to treatment recommendationsCornea200625890090717102664
- MiljanovicBDanaRSullivanDASchaumbergDAImpact of dry eye syndrome on vision-related quality of lifeAm J Ophthalmol2007143340941517317388
- MarshPPflugfelderSCTopical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndromeOphthalmology1999106481181610201607
- PflugfelderSCAntiinflammatory therapy for dry eyeAm J Ophthalmol2004137233734214962426
- RajpalRKDigbyDD’AversaGMahFHollanderDAConwayTIntraocular pressure elevations with loteprednol etabonate: a retrospective chart reviewJ Ocul Pharmacol Ther201127330530821574815
- SallKStevensonODMundorfTKReisBLTwo multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study GroupOphthalmology2000107463163910768324
- RaoSNTopical cyclosporine 0.05% for the prevention of dry eye disease progressionJ Ocul Pharmacol Ther201026215716420415623
- HomMMUse of cyclosporine 0.05% ophthalmic emulsion for contact lens-intolerant patientsEye Contact Lens200632210911116538135
- SchechterBAKatzRSFriedmanLSEfficacy of topical cyclosporine for the treatment of ocular rosaceaAdv Ther200926665165919551353
- SchaumbergDASullivanDABuringJEDanaMRPrevalence of dry eye syndrome among US womenAm J Ophthalmol2003136231832612888056
- SchaumbergDADanaRBuringJESullivanDAPrevalence of dry eye disease among US men: estimates from the Physicians’ Health StudiesArch Ophthalmol2009127676376819506195
- LempMAManagement of dry eye diseaseAm J Manag Care2008143 SupplS88S10118452372
- WilsonSEPerryHDLong-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatmentOphthalmology20071141767917070588
- SuMYPerryHDBarsamAThe effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapyCornea201130101098110421407074
- RaoSNReversibility of dry eye deceleration after topical cyclosporine 0.05% withdrawalJ Ocul Pharmacol Ther201127660360921999340
- WilsonSEStultingRDAgreement of physician treatment practices with the international task force guidelines for diagnosis and treatment of dry eye diseaseCornea200726328428917413954
- SheppardJDScoperSVSamudreSTopical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye diseaseJ Ocul Pharmacol Ther2011271232721133792
- Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop2007Ocul Surf20075216317817508120